The impact of viral genotype on pathogenesis and disease severity: Respiratory syncytial virus and human rhinoviruses

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 761-768

  Moore, Martin L ^a,b   Stokes, Kate L ^a,b,d   Hartert, Tina V ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AIRWAY OBSTRUCTION; ASTHMA; CAUSE OF DEATH; CHILD DEATH; DESQUAMATION; DISEASE SEVERITY; GENOTYPE; HUMAN; HUMAN RHINOVIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; INFANT; LOWER RESPIRATORY TRACT INFECTION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHENOTYPE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; UPPER RESPIRATORY TRACT INFECTION; VIRAL GENETICS; VIRUS PNEUMONIA; VIRUS STRAIN;

ANIMALS; GENOTYPE; HUMANS; NEUTROPHILS; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS; SEVERITY OF ILLNESS INDEX; VIRAL FUSION PROTEINS;

EID: 84889080009     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.016     Document Type: Review

References (75)

1. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T., Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007, 3:1414-1421.
2. Tumpey T.M., Garcia-Sastre A., Mikulasova A., Taubenberger J.K., Swayne D.E., Palese P., Basler C.F. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 2002, 99:13849-13854.
3. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A., Van Rooijen N., Katz J.M., et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005, 79:14933-14944.
4. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., Tumpey T.M., Pappas C., Perrone L.A., Martinez O., et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008, 455:532-536.
5. Sauter D., Schindler M., Specht A., Landford W.N., Munch J., Kim K.A., Votteler J., Schubert U., Bibollet-Ruche F., Keele B.F., et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
6. Gotz N., Sauter D., Usmani S.M., Fritz J.V., Goffinet C., Heigele A., Geyer M., Bibollet-Ruche F., Learn G.H., Fackler O.T., et al. Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host. Cell Host Microbe 2012, 12:373-380.
7. Sullivan B.M., Emonet S.F., Welch M.J., Lee A.M., Campbell K.P., de la Torre J.C., Oldstone M.B. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A 2011, 108:2969-2974.
8. Fukuyama S., Kawaoka Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 2011, 23:481-486.
9. Collins P.L., Crowe J.E., Knipe D.M., Howley P.M. Respiratory syncytial virus and metapneumovirus. Fields Virology 2006, vol 5. Lippincott, Williams, & Wilkins.
10. Karron R.A. Respiratory syncytial virus and parainfluenza virus vaccines. Vaccines 2008, 1283-1293. Elsevier Inc., Offit, PA. edn 5. S.A. Plotkin, W.A. Orenstein (Eds.).
11. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., O'Brien K.L., Roca A., Wright P.F., Bruce N., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
12. Hastie M.L., Headlam M.J., Patel N.B., Bukreyev A.A., Buchholz U.J., Dave K.A., Norris E.L., Wright C.L., Spann K.M., Collins P.L., et al. The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways. Mol Cell Proteomics 2012, 11:108-127.
13. Pelletier A.J., Mansbach J.M., Camargo C.A. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006, 118:2418-2423.
14. Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., Martinez F.D. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003, 111:661-675. quiz 676.
15. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161:1501-1507.
16. Wu P., Dupont W.D., Griffin M.R., Carroll K.N., Mitchel E.F., Gebretsadik T., Hartert T.V. Evidence of a causal role of winter virus infection during infancy on early childhood asthma. Am J Respir Crit Care Med 2008, 178:1123-1129.
17. Johnson J.E., Gonzales R.A., Olson S.J., Wright P.F., Graham B.S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007, 20:108-119.
18. Rogers D.F. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol 2004, 4:241-250.
19. Welliver T.P., Garofalo R.P., Hosakote Y., Hintz K.H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S., Ogra P.L., et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007, 195:1126-1136.
20. Anderson L.J., Hierholzer J.C., Tsou C., Hendry R.M., Fernie B.F., Stone Y., McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 1985, 151:626-633.
21. Botosso V.F., Zanotto P.M., Ueda M., Arruda E., Gilio A.E., Vieira S.E., Stewien K.E., Peret T.C., Jamal L.F., Pardini M.I., et al. Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 2009, 5:e1000254.
22. Peret T.C., Hall C.B., Hammond G.W., Piedra P.A., Storch G.A., Sullender W.M., Tsou C., Anderson L.J. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 2000, 181:1891-1896.
23. Walsh E.E., McConnochie K.M., Long C.E., Hall C.B. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis 1997, 175:814-820.
24. Tran D.N., Pham T.M., Ha M.T., Tran T.T., Dang T.K., Yoshida L.M., Okitsu S., Hayakawa S., Mizuguchi M., Ushijima H. Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam. PLoS ONE 2013, 8:e45436.
25. Martinello R.A., Chen M.D., Weibel C., Kahn J.S. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 2002, 186:839-842.
26. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., Pickles R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2002, 76:5654-5666.
27. Villenave R., Thavagnanam S., Sarlang S., Parker J., Douglas I., Skibinski G., Heaney L.G., McKaigue J.P., Coyle P.V., Shields M.D., et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A 2012, 109:5040-5045.
28. Ioannidis I., McNally B., Willette M., Peeples M.E., Chaussabel D., Durbin J.E., Ramilo O., Mejias A., Flano E. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 2012, 86:5422-5436.
29. Villenave R., O'Donoghue D., Thavagnanam S., Touzelet O., Skibinski G., Heaney L.G., McKaigue J.P., Coyle P.V., Shields M.D., Power U.F. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Virology J 2011, 8:43.
30. Herlocher M.L., Ewasyshyn M., Sambhara S., Gharaee-Kermani M., Cho D., Lai J., Klein M., Maassab H.F. Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine. Vaccine 1999, 17:172-181.
31. Maassab H.F. Adaptation and growth characteristics of influenza virus at 25°C. Nature 1967, 213:612-614.
32. Moore M.L., Peebles R.S. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 2006, 112:405-424.
33. Olson M.R., Hartwig S.M., Varga S.M. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. J Immunol 2008, 181:7958-7968.
34. Peebles R.S., Sheller J.R., Collins R.D., Jarzecka A.K., Mitchell D.B., Parker R.A., Graham B.S. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice. J Med Virol 2001, 63:178-188.
35. Tekkanat K.K., Maassab H.F., Cho D.S., Lai J.J., John A., Berlin A., Kaplan M.H., Lukacs N.W. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 2001, 166:3542-3548.
36. Lukacs N.W., Moore M.L., Rudd B.D., Berlin A.A., Collins R.D., Olson S.J., Ho S.B., Peebles R.S. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol 2006, 169:977-986.
37. Moore M.L., Chi M.H., Luongo C., Lukacs N.W., Polosukhin V.V., Huckabee M.M., Newcomb D.C., Buchholz U.J., Crowe J.E., Goleniewska K., et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol 2009, 83:4185-4194.
38. Mukherjee S., Lindell D.M., Berlin A.A., Morris S.B., Shanley T.P., Hershenson M.B., Lukacs N.W. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011, 179:248-258.
39. Zhou W., Hashimoto K., Moore M.L., Elias J.A., Zhu Z., Durbin J., Colasurdo G., Rutigliano J.A., Chiappetta C.L., Goleniewska K., et al. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse. Microbes Infect 2006, 8:2880-2889.
40. Krishnamoorthy N., Khare A., Oriss T.B., Raundhal M., Morse C., Yarlagadda M., Wenzel S.E., Moore M.L., Peebles R.S., Ray A., et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med 2012, 18:1525-1530.
41. Lee H.C., Headley M.B., Loo Y.M., Berlin A., Gale M., Debley J.S., Lukacs N.W., Ziegler S.F. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol 2012, 130:1187-1196. e1185.
42. Stokes K.L., Chi M.H., Sakamoto K., Newcomb D.C., Currier M.G., Huckabee M.M., Lee S., Goleniewska K., Pretto C., Williams J.V., et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol 2011, 85:5782-5793.
43. Stokes K.L., Currier M.G., Sakamoto K., Lee S., Collins P.L., Plemper R.K., Moore M.L. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic RSV infection. J Virol 2013, 87:10070-10082.
44. McLellan J.S., Chen M., Leung S., Graepel K.W., Du X., Yang Y., Zhou T., Baxa U., Yasuda E., Beaumont T., et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 2013, 340:1113-1117.
45. McLellan J.S., Yang Y., Graham B.S., Kwong P.D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol 2011, 85:7788-7796.
46. Luque L.E., Bridges O.A., Mason J.N., Boyd K.L., Portner A., Russell C.J. Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol 2010, 84:810-821.
47. Busse P.J., Zhang T.F., Srivastava K., Lin B.P., Schofield B., Sealfon S.C., Li X.M. Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo. J Allergy Clin Immunol 2005, 116:1256-1263.
48. Shim J.J., Dabbagh K., Ueki I.F., Dao-Pick T., Burgel P.R., Takeyama K., Tam D.C., Nadel J.A. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 2001, 280:L134-L140.
49. Shao M.X., Nadel J.A. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol 2005, 175:4009-4016.
50. Wang S.Z., Xu H., Wraith A., Bowden J.J., Alpers J.H., Forsyth K.D. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur Respir J 1998, 12:612-618.
51. Fox J.P. Is a rhinovirus vaccine possible?. Am J Epidemiol 1976, 103:345-354.
52. Hamory B.H., Hamparian V.V., Conant R.M., Gwaltney J.M. Human responses to two decavalent rhinovirus vaccines. J Infect Dis 1975, 132:623-629.
53. Barclay W.S., al-Nakib W., Higgins P.G., Tyrrell D.A. The time course of the humoral immune response to rhinovirus infection. Epidemiol Infect 1989, 103:659-669.
54. Cooney M.K., Fox J.P., Kenny G.E. Antigenic groupings of 90 rhinovirus serotypes. Infect Immun 1982, 37:642-647.
55. Sherry B., Mosser A.G., Colonno R.J., Rueckert R.R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 1986, 57:246-257.
56. Rossmann M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.J., Johnson J.E., Kamer G., Luo M., Mosser A.G., et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985, 317:145-153.
57. Jacobs S.E., Lamson D.M., St George K., Walsh T.J. Human rhinoviruses. Clin Microbiol Rev 2013, 26:135-162.
58. McIntyre C.L., Knowles N.J., Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol 2013, 94:1791-1806.
59. Palmenberg A.C., Spiro D., Kuzmickas R., Wang S., Djikeng A., Rathe J.A., Fraser-Liggett C.M., Liggett S.B. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009, 324:55-59.
60. Bochkov Y.A., Palmenberg A.C., Lee W.M., Rathe J.A., Amineva S.P., Sun X., Pasic T.R., Jarjour N.N., Liggett S.B., Gern J.E. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 2011, 17:627-632.
61. Traub S., Nikonova A., Carruthers A., Dunmore R., Vousden K.A., Gogsadze L., Hao W., Zhu Q., Bernard K., Zhu J., et al. An anti-human icam-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog 2013, 9:e1003520.
62. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229.
63. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., Johnston S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
64. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., Holgate S.T., Davies D.E. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201:937-947.
65. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., Kebadze T., Mallia P., Stanciu L.A., Parker H.L., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12:1023-1026.
66. Khetsuriani N., Lu X., Teague W.G., Kazerouni N., Anderson L.J., Erdman D.D. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis 2008, 14:1793-1796.
67. Miller E.K., Edwards K.M., Weinberg G.A., Iwane M.K., Griffin M.R., Hall C.B., Zhu Y., Szilagyi P.G., Morin L.L., Heil L.H., et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 2009, 123:98-104. e101.
68. Lee W.M., Lemanske R.F., Evans M.D., Vang F., Pappas T., Gangnon R., Jackson D.J., Gern J.E. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 2012, 186:886-891.
69. Bartlett N.W., Walton R.P., Edwards M.R., Aniscenko J., Caramori G., Zhu J., Glanville N., Choy K.J., Jourdan P., Burnet J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 2008, 14:199-204.
70. Newcomb D.C., Sajjan U.S., Nagarkar D.R., Wang Q., Nanua S., Zhou Y., McHenry C.L., Hennrick K.T., Tsai W.C., Bentley J.K., et al. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am J Respir Crit Care Med 2008, 177:1111-1121.
71. Jartti T., Korppi M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol 2011, 22:350-355.
72. Lemanske R.F., Jackson D.J., Gangnon R.E., Evans M.D., Li Z., Shult P.A., Kirk C.J., Reisdorf E., Roberg K.A., Anderson E.L., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005, 116:571-577.
73. Carroll K.N., Gebretsadik T., Minton P., Woodward K., Liu Z., Miller E.K., Williams J.V., Dupont W.D., Hartert T.V. Influence of maternal asthma on the cause and severity of infant acute respiratory tract infections. J Allergy Clin Immunol 2012, 129:1236-1242.
74. Jackson D.J., Evans M.D., Gangnon R.E., Tisler C.J., Pappas T.E., Lee W.M., Gern J.E., Lemanske R.F. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012, 185:281-285.
75. Caliskan M., Bochkov Y.A., Kreiner-Moller E., Bonnelykke K., Stein M.M., Du G., Bisgaard H., Jackson D.J., Gern J.E., Lemanske R.F., et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013, 368:1398-1407.